SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-006441
Filing Date
2023-04-11
Accepted
2023-04-11 17:04:50
Documents
1
Period of Report
2023-04-10

Document Format Files

Seq Description Document Type Size
1 form4-04112023_090443.html 4  
1 form4-04112023_090443.xml 4 7112
  Complete submission text file 0001415889-23-006441.txt   8492
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS CORP. 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Ragosa Mark (Reporting) CIK: 0001835458 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 23813961